-
1
-
-
0029925375
-
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
-
Clemente CG, Mihm Jr MC, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77: 1303-10
-
(1996)
Cancer
, vol.77
, pp. 1303-1310
-
-
Clemente, C.G.1
Mihm M.C., Jr.2
Bufalino, R.3
Zurrida, S.4
Collini, P.5
Cascinelli, N.6
-
2
-
-
0034544532
-
A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response
-
Dunbar PR, Smith CL, Chao D et al. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J Immunol 2000; 165:6644-52
-
(2000)
J Immunol
, vol.165
, pp. 6644-6652
-
-
Dunbar, P.R.1
Smith, C.L.2
Chao, D.3
-
3
-
-
0032476616
-
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T-lymphocytes
-
Romero P, Dunbar PR, Valmori D et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T-lymphocytes. J Exp Med 1998; 188: 1641-50
-
(1998)
J Exp Med
, vol.188
, pp. 1641-1650
-
-
Romero, P.1
Dunbar, P.R.2
Valmori, D.3
-
4
-
-
0030787373
-
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
-
Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997; 182: 318-24
-
(1997)
J Pathol
, vol.182
, pp. 318-324
-
-
Ropponen, K.M.1
Eskelinen, M.J.2
Lipponen, P.K.3
Alhava, E.4
Kosma, V.M.5
-
5
-
-
0035060624
-
Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status
-
Michael-Robinson JM, Biemer-Huttmann A, Purdie DM et al. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 2001; 48: 360-6
-
(2001)
Gut
, vol.48
, pp. 360-366
-
-
Michael-Robinson, J.M.1
Biemer-Huttmann, A.2
Purdie, D.M.3
-
6
-
-
0034283019
-
Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer
-
Nagorsen D, Keilholz U, Rivoltini L et al. Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Cancer Res 2000; 60: 4850-4
-
(2000)
Cancer Res
, vol.60
, pp. 4850-4854
-
-
Nagorsen, D.1
Keilholz, U.2
Rivoltini, L.3
-
7
-
-
0029957792
-
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
-
De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996; 93: 7149-53
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 7149-7153
-
-
De Smet, C.1
De Backer, O.2
Faraoni, I.3
Lurquin, C.4
Brasseur, F.5
Boon, T.6
-
8
-
-
0028050181
-
Structure, chromosomal localization, and expression of 12 genes of the MAGE family
-
De Plaen E, Arden K, Traversari C et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40: 360-9
-
(1994)
Immunogenetics
, vol.40
, pp. 360-369
-
-
De Plaen, E.1
Arden, K.2
Traversari, C.3
-
9
-
-
0028952240
-
BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T-lymphocytes
-
Boel P, Wildmann C, Sensi ML et al. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T-lymphocytes. Immunity 1995; 2: 167-75
-
(1995)
Immunity
, vol.2
, pp. 167-175
-
-
Boel, P.1
Wildmann, C.2
Sensi, M.L.3
-
10
-
-
0033168930
-
Characterization of the GAGE genes that are expressed in various human cancers and in normal testis
-
De Backer O, Arden KC, Boretti M et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 1999; 59: 3157-65
-
(1999)
Cancer Res
, vol.59
, pp. 3157-3165
-
-
De Backer, O.1
Arden, K.C.2
Boretti, M.3
-
11
-
-
1842398548
-
The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40
-
Tureci O, Sahin U, Schobert I et al. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996; 56: 4766-72
-
(1996)
Cancer Res
, vol.56
, pp. 4766-4772
-
-
Tureci, O.1
Sahin, U.2
Schobert, I.3
-
12
-
-
0030946527
-
Identification of potential HLA-A*0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA)
-
Ras E, van der Burg SH, Zegveld ST et al. Identification of potential HLA-A*0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA). Hum Immunol 1997; 53: 81-9
-
(1997)
Hum Immunol
, vol.53
, pp. 81-89
-
-
Ras, E.1
Van der Burg, S.H.2
Zegveld, S.T.3
-
13
-
-
0035874893
-
Generation of cytotoxic T-lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule
-
Trojan A, Witzens M, Schultze JL et al. Generation of cytotoxic T-lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule. Cancer Res 2001; 61: 4761-5
-
(2001)
Cancer Res
, vol.61
, pp. 4761-4765
-
-
Trojan, A.1
Witzens, M.2
Schultze, J.L.3
-
14
-
-
0033024724
-
Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma
-
Mosolits S, Harmenberg U, Ruden U et al. Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma. Cancer Immunol Immunother 1999; 47: 315-20
-
(1999)
Cancer Immunol Immunother
, vol.47
, pp. 315-320
-
-
Mosolits, S.1
Harmenberg, U.2
Ruden, U.3
-
15
-
-
0021345777
-
Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues
-
Wagener C, Petzold P, Kohler W, Totovic V. Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues. Int J Cancer 1984; 33: 469-75
-
(1984)
Int J Cancer
, vol.33
, pp. 469-475
-
-
Wagener, C.1
Petzold, P.2
Kohler, W.3
Totovic, V.4
-
16
-
-
0028022877
-
Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients
-
Esteban JM, Felder B, Ahn C, Simpson JF, Battifora H, Shively JE. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients. Cancer 1994; 74: 1575-83
-
(1994)
Cancer
, vol.74
, pp. 1575-1583
-
-
Esteban, J.M.1
Felder, B.2
Ahn, C.3
Simpson, J.F.4
Battifora, H.5
Shively, J.E.6
-
17
-
-
0033963880
-
Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine
-
Conry RM, Allen KO, Lee S, Moore SE, Shaw DR, LoBuglio AF. Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine. Clin Cancer Res 2000; 6: 34-41
-
(2000)
Clin Cancer Res
, vol.6
, pp. 34-41
-
-
Conry, R.M.1
Allen, K.O.2
Lee, S.3
Moore, S.E.4
Shaw, D.R.5
LoBuglio, A.F.6
-
18
-
-
0029042336
-
Generation of human cytotoxic T-cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
-
Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Generation of human cytotoxic T-cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 1995; 87: 982-90
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 982-990
-
-
Tsang, K.Y.1
Zaremba, S.2
Nieroda, C.A.3
Zhu, M.Z.4
Hamilton, J.M.5
Schlom, J.6
-
19
-
-
0031937298
-
The multi-epitope approach for immunotherapy for cancer: Identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors
-
Kawashima I, Hudson SJ, Tsai V et al. The multi-epitope approach for immunotherapy for cancer: Identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum Immunol 1998; 59:1-14.
-
(1998)
Hum Immunol
, vol.59
, pp. 1-14
-
-
Kawashima, I.1
Hudson, S.J.2
Tsai, V.3
-
20
-
-
0033524378
-
Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T-lymphocyte
-
Nukaya I, Yasumoto M, Iwasaki T et al. Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T-lymphocyte. Int J Cancer 1999; 80: 92-7
-
(1999)
Int J Cancer
, vol.80
, pp. 92-97
-
-
Nukaya, I.1
Yasumoto, M.2
Iwasaki, T.3
-
21
-
-
0026048664
-
Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives
-
Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives. J Clin Lab Anal 1991; 5: 344-66
-
(1991)
J Clin Lab Anal
, vol.5
, pp. 344-366
-
-
Thompson, J.A.1
Grunert, F.2
Zimmermann, W.3
-
22
-
-
0033616484
-
Colorectal cancer
-
Midgley R, Kerr D. Colorectal cancer. Lancet 1999; 353: 391-9
-
(1999)
Lancet
, vol.353
, pp. 391-399
-
-
Midgley, R.1
Kerr, D.2
-
23
-
-
0033025229
-
Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer
-
Ward RL, Hawkins NJ, Coomber D, Disis ML. Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer. Hum Immunol 1999; 60: 510-5
-
(1999)
Hum Immunol
, vol.60
, pp. 510-515
-
-
Ward, R.L.1
Hawkins, N.J.2
Coomber, D.3
Disis, M.L.4
-
25
-
-
0028989973
-
MUC-1 epithelial tumor mucin-based immunity and cancer vaccines
-
Finn OJ, Jerome KR, Henderson RA et al. MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 1995; 145: 61-89
-
(1995)
Immunol Rev
, vol.145
, pp. 61-89
-
-
Finn, O.J.1
Jerome, K.R.2
Henderson, R.A.3
-
26
-
-
0028840265
-
Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients
-
Gourevitch MM, von Mensdorff-Pouilly S, Litvinov SV et al. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br J Cancer 1995; 72: 934-8
-
(1995)
Br J Cancer
, vol.72
, pp. 934-938
-
-
Gourevitch, M.M.1
Von Mensdorff-Pouilly, S.2
Litvinov, S.V.3
-
27
-
-
0025834851
-
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells
-
Jerome KR, Barnd DL, Bendt KM et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 1991; 51: 2908-16
-
(1991)
Cancer Res
, vol.51
, pp. 2908-2916
-
-
Jerome, K.R.1
Barnd, D.L.2
Bendt, K.M.3
-
28
-
-
0028875822
-
Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin
-
Domenech N, Henderson RA, Finn OJ. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J Immunol 1995; 155: 4766-74
-
(1995)
J Immunol
, vol.155
, pp. 4766-4774
-
-
Domenech, N.1
Henderson, R.A.2
Finn, O.J.3
-
29
-
-
0035254940
-
Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T- cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic mice
-
Heukamp LC, van der Burg SH, Drijfhout JW, Melief CJ, Taylor-Papadimitriou J, Offringa R. Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T- cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic mice. Int J Cancer 2001; 91: 385-92
-
(2001)
Int J Cancer
, vol.91
, pp. 385-392
-
-
Heukamp, L.C.1
Van der Burg, S.H.2
Drijfhout, J.W.3
Melief, C.J.4
Taylor-Papadimitriou, J.5
Offringa, R.6
-
30
-
-
0031905632
-
Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas
-
Gnjatic S, Cai Z, Viguier M, Chouaib S, Guillet JG, Choppin J. Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J Immunol 1998; 160: 328-33
-
(1998)
J Immunol
, vol.160
, pp. 328-333
-
-
Gnjatic, S.1
Cai, Z.2
Viguier, M.3
Chouaib, S.4
Guillet, J.G.5
Choppin, J.6
-
31
-
-
0035399602
-
Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens
-
Linnebacher M, Gebert J, Rudy W et al. Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens. Int J Cancer 2001; 93: 6-11
-
(2001)
Int J Cancer
, vol.93
, pp. 6-11
-
-
Linnebacher, M.1
Gebert, J.2
Rudy, W.3
-
33
-
-
0035818515
-
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
-
Saeterdal I, Bjorheim J, Lislerud K et al. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 2001; 98: 13255-60
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 13255-13260
-
-
Saeterdal, I.1
Bjorheim, J.2
Lislerud, K.3
-
34
-
-
0027988317
-
Source of unique tumour antigens
-
Townsend A, Ohlen C, Rogers M, Edwards J, Mukherjee S, Bastin J. Source of unique tumour antigens. Nature 1994; 371: 662
-
(1994)
Nature
, vol.371
, pp. 662
-
-
Townsend, A.1
Ohlen, C.2
Rogers, M.3
Edwards, J.4
Mukherjee, S.5
Bastin, J.6
-
36
-
-
0029743737
-
Phenotypic analysis of antigen-specific T-lymphocytes
-
Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T-lymphocytes. Science 1996; 274: 94-6
-
(1996)
Science
, vol.274
, pp. 94-96
-
-
Altman, J.D.1
Moss, P.A.2
Goulder, P.J.3
-
37
-
-
0033564637
-
Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma
-
Dunbar PR, Chen JL, Chao D et al. Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. J Immunol 1999; 162: 6959-62
-
(1999)
J Immunol
, vol.162
, pp. 6959-6962
-
-
Dunbar, P.R.1
Chen, J.L.2
Chao, D.3
-
38
-
-
0034693390
-
Quantitation of antigen-reactive T-cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: A four-centre comparative trial
-
Scheibenbogen C, Romero P, Rivoltini L et al. Quantitation of antigen-reactive T-cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: A four-centre comparative trial. J Immunol Methods 2000; 244: 81-9
-
(2000)
J Immunol Methods
, vol.244
, pp. 81-89
-
-
Scheibenbogen, C.1
Romero, P.2
Rivoltini, L.3
-
39
-
-
0034600786
-
HIV-specific CD8(+) T-cells produce antiviral cytokines but are impaired in cytolytic function
-
Appay V, Nixon DF, Donahoe SM et al. HIV-specific CD8(+) T-cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192: 63-75
-
(2000)
J Exp Med
, vol.192
, pp. 63-75
-
-
Appay, V.1
Nixon, D.F.2
Donahoe, S.M.3
-
40
-
-
0031771557
-
Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen
-
Samanci A, Yi Q, Fagerberg J et al. Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. Cancer Immunol Immunother 1998; 47: 131-42
-
(1998)
Cancer Immunol Immunother
, vol.47
, pp. 131-142
-
-
Samanci, A.1
Yi, Q.2
Fagerberg, J.3
-
41
-
-
0027512782
-
Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-Year median follow-up of a phase III prospectively randomized trial
-
Hoover Jr HC, Brandhorst JS, Peters LC et al. Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-Year median follow-up of a phase III prospectively randomized trial. J Clin Oncol 1993; 11: 390-9
-
(1993)
J Clin Oncol
, vol.11
, pp. 390-399
-
-
Hoover H.C., Jr.1
Brandhorst, J.S.2
Peters, L.C.3
-
42
-
-
0033985949
-
Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283
-
Harris JE, Ryan L, Hoover Jr HC et al. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol 2000; 18: 148-57
-
(2000)
J Clin Oncol
, vol.18
, pp. 148-157
-
-
Harris, J.E.1
Ryan, L.2
Hoover H.C., Jr.3
-
43
-
-
0033616482
-
Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial
-
Vermorken JB, Claessen AM, van Tinteren H et al. Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial. Lancet 1999; 353: 345-50
-
(1999)
Lancet
, vol.353
, pp. 345-350
-
-
Vermorken, J.B.1
Claessen, A.M.2
Van Tinteren, H.3
-
44
-
-
0029642252
-
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
-
Marchand M, Weynants P, Rankin E et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995; 63: 883-5
-
(1995)
Int J Cancer
, vol.63
, pp. 883-885
-
-
Marchand, M.1
Weynants, P.2
Rankin, E.3
-
46
-
-
0031573840
-
+ T-cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations
-
+ T-cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations. Cell Immunol 1997; 182: 137-51
-
(1997)
Cell Immunol
, vol.182
, pp. 137-151
-
-
Abrams, S.I.1
Khleif, S.N.2
Bergmann-Leitner, E.S.3
-
47
-
-
0030749292
-
+ T-lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation
-
+ T-lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. Int J Cancer 1997; 72: 784-90
-
(1997)
Int J Cancer
, vol.72
, pp. 784-790
-
-
Gjertsen, M.K.1
Bjorheim, J.2
Saeterdal, I.3
Myklebust, J.4
Gaudernack, G.5
-
48
-
-
0035866326
-
A striking property of recombinant poxviruses: Efficient inducers of in vivo expansion of primed CD8(+) T- cells
-
Zavala F, Rodrigues M, Rodriguez D, Rodriguez JR, Nussenzweig RS, Esteban M. A striking property of recombinant poxviruses: Efficient inducers of in vivo expansion of primed CD8(+) T- cells. Virology 2001; 280: 155-9
-
(2001)
Virology
, vol.280
, pp. 155-159
-
-
Zavala, F.1
Rodrigues, M.2
Rodriguez, D.3
Rodriguez, J.R.4
Nussenzweig, R.S.5
Esteban, M.6
-
49
-
-
0031924077
-
+ T-cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
-
+ T-cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 1998; 4: 397-402
-
(1998)
Nat Med
, vol.4
, pp. 397-402
-
-
Schneider, J.1
Gilbert, S.C.2
Blanchard, T.J.3
-
50
-
-
0032033577
-
Enhancement of MHC class I-restricted peptide-specific T-cell induction by a DNA prime/MVA boost vaccination regime
-
Hanke T, Blanchard TJ, Schneider J et al. Enhancement of MHC class I-restricted peptide-specific T-cell induction by a DNA prime/MVA boost vaccination regime. Vaccine 1998; 16: 439-45
-
(1998)
Vaccine
, vol.16
, pp. 439-445
-
-
Hanke, T.1
Blanchard, T.J.2
Schneider, J.3
-
51
-
-
0000908124
-
Phase I study of recombinant vaccinia virus (rV) that expresses human carcinoembryonic antigen (CEA) in adult patients with adenocarcinomas
-
Hamilton JM, Chen AP, Nguyen B et al. Phase I study of recombinant vaccinia virus (rV) that expresses human carcinoembryonic antigen (CEA) in adult patients with adenocarcinomas [abstract]. Proc ASCO 1994; 961
-
(1994)
Proc ASCO
, pp. 961
-
-
Hamilton, J.M.1
Chen, A.P.2
Nguyen, B.3
-
52
-
-
0033973608
-
Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine
-
Zhu MZ, Marshall J, Cole D, Schlom J, Tsang KY. Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine. Clin Cancer Res 2000; 6: 24-33
-
(2000)
Clin Cancer Res
, vol.6
, pp. 24-33
-
-
Zhu, M.Z.1
Marshall, J.2
Cole, D.3
Schlom, J.4
Tsang, K.Y.5
-
53
-
-
0033766694
-
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
-
Horig H, Lee DS, Conkright W et al. Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunol Immunother 2000; 49: 504-14
-
(2000)
Cancer Immunol Immunother
, vol.49
, pp. 504-514
-
-
Horig, H.1
Lee, D.S.2
Conkright, W.3
-
54
-
-
0034900416
-
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma
-
von Mehren M, Arlen P, Gulley J et al. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clin Cancer Res 2001; 7: 1181-91
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1181-1191
-
-
Von Mehren, M.1
Arlen, P.2
Gulley, J.3
-
55
-
-
0034551730
-
Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses
-
Marshall JL, Hoyer RJ, Toomey MA et al. Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. J Clin Oncol 2000; 18: 3964-73
-
(2000)
J Clin Oncol
, vol.18
, pp. 3964-3973
-
-
Marshall, J.L.1
Hoyer, R.J.2
Toomey, M.A.3
-
56
-
-
0034880680
-
Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas
-
Sadanaga N, Nagashima H, Mashino K et al. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin Cancer Res 2001; 7: 2277-84
-
(2001)
Clin Cancer Res
, vol.7
, pp. 2277-2284
-
-
Sadanaga, N.1
Nagashima, H.2
Mashino, K.3
-
57
-
-
0033017065
-
A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
-
Morse MA, Deng Y, Coleman D et al. A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin Cancer Res 1999; 5:1331-8
-
(1999)
Clin Cancer Res
, vol.5
, pp. 1331-1338
-
-
Morse, M.A.1
Deng, Y.2
Coleman, D.3
-
58
-
-
0036124550
-
Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen
-
Itoh T, Ueda Y, Kawashima I et al. Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen. Cancer Immunol Immunother 2002; 51:99-106
-
(2002)
Cancer Immunol Immunother
, vol.51
, pp. 99-106
-
-
Itoh, T.1
Ueda, Y.2
Kawashima, I.3
-
59
-
-
0035902607
-
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
-
Fong L, Hou Y, Rivas A et al. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci USA 2001; 98: 8809-14
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 8809-8814
-
-
Fong, L.1
Hou, Y.2
Rivas, A.3
-
60
-
-
0030882684
-
Identification of an enhancer agonist cytotoxic T-lymphocyte peptide from human carcinoembryonic antigen
-
Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J. Identification of an enhancer agonist cytotoxic T-lymphocyte peptide from human carcinoembryonic antigen. Cancer Res 1997; 57: 4570-7
-
(1997)
Cancer Res
, vol.57
, pp. 4570-4577
-
-
Zaremba, S.1
Barzaga, E.2
Zhu, M.3
Soares, N.4
Tsang, K.Y.5
Schlom, J.6
-
61
-
-
0343965762
-
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
-
Riethmuller G, Holz E, Schlimok G et al. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial. J Clin Oncol 1998; 16: 1788-94
-
(1998)
J Clin Oncol
, vol.16
, pp. 1788-1794
-
-
Riethmuller, G.1
Holz, E.2
Schlimok, G.3
-
62
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
-
Slamon DJ, Leyland-Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783-92
-
(2001)
N Engl J Med
, vol.344
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
-
63
-
-
0027935133
-
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer
-
Welt S, Divgi CR, Kemeny N et al. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol 1994; 12: 1561-71
-
(1994)
J Clin Oncol
, vol.12
, pp. 1561-1571
-
-
Welt, S.1
Divgi, C.R.2
Kemeny, N.3
-
64
-
-
8944220716
-
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer
-
Welt S, Scott AM, Divgi CR et al. Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol 1996; 14: 1787-97
-
(1996)
J Clin Oncol
, vol.14
, pp. 1787-1797
-
-
Welt, S.1
Scott, A.M.2
Divgi, C.R.3
-
65
-
-
0035884115
-
Serological analysis of human antihuman antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33
-
Ritter G, Cohen LS, Williams Jr C, Richards EC, Old LJ, Welt S. Serological analysis of human antihuman antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33. Cancer Res 2001; 61: 6851-9
-
(2001)
Cancer Res
, vol.61
, pp. 6851-6859
-
-
Ritter, G.1
Cohen, L.S.2
Williams C., Jr.3
Richards, E.C.4
Old, L.J.5
Welt, S.6
-
66
-
-
0015956495
-
Towards a network theory of the immune system
-
Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974; 125C: 373-89
-
(1974)
Ann Immunol (Paris)
, vol.125 C
, pp. 373-389
-
-
Jerne, N.K.1
-
67
-
-
0029144584
-
Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine
-
Foon KA, Chakraborty M, John WJ, Sherratt A, Kohler H, Bhattacharya-Chatterjee M. Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J Clin Invest 1995; 96: 334-42
-
(1995)
J Clin Invest
, vol.96
, pp. 334-342
-
-
Foon, K.A.1
Chakraborty, M.2
John, W.J.3
Sherratt, A.4
Kohler, H.5
Bhattacharya-Chatterjee, M.6
-
68
-
-
0029992407
-
Mechanisms of loss of HLA class I expression on colorectal tumor cells
-
Browning M, Petronzelli F, Bicknell D et al. Mechanisms of loss of HLA class I expression on colorectal tumor cells. Tissue Antigens 1996; 47: 364-71
-
(1996)
Tissue Antigens
, vol.47
, pp. 364-371
-
-
Browning, M.1
Petronzelli, F.2
Bicknell, D.3
-
69
-
-
0035796591
-
The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR)
-
Meyaard L, van der Vuurst de Vries AR, de Ruiter T, Lanier LL, Phillips JH, Clevers H. The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR). J Exp Med 2001; 194: 107-12
-
(2001)
J Exp Med
, vol.194
, pp. 107-112
-
-
Meyaard, L.1
Van der Vuurst de Vries, A.R.2
De Ruiter, T.3
Lanier, L.L.4
Phillips, J.H.5
Clevers, H.6
-
70
-
-
0035180067
-
Control of intestinal inflammation by regulatory T-cells
-
Singh B, Read S, Asseman C et al. Control of intestinal inflammation by regulatory T-cells. Immunol Rev 2001; 182: 190-200
-
(2001)
Immunol Rev
, vol.182
, pp. 190-200
-
-
Singh, B.1
Read, S.2
Asseman, C.3
-
71
-
-
0030902366
-
The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma
-
Coca S, Perez-Piqueras J, Martinez D et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997; 79: 2320-8
-
(1997)
Cancer
, vol.79
, pp. 2320-2328
-
-
Coca, S.1
Perez-Piqueras, J.2
Martinez, D.3
-
72
-
-
0037017387
-
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK-cells
-
Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK-cells. J Exp Med 2002; 195: 343-51
-
(2002)
J Exp Med
, vol.195
, pp. 343-351
-
-
Ferlazzo, G.1
Tsang, M.L.2
Moretta, L.3
Melioli, G.4
Steinman, R.M.5
Munz, C.6
-
73
-
-
0037017379
-
Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells
-
Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002; 195: 335-41
-
(2002)
J Exp Med
, vol.195
, pp. 335-341
-
-
Piccioli, D.1
Sbrana, S.2
Melandri, E.3
Valiante, N.M.4
-
74
-
-
0033618504
-
Activation of NK-cells and T-cells by NKG2D, a receptor for stress-inducible MICA
-
Bauer S, Groh V, Wu J et al. Activation of NK-cells and T-cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727-9
-
(1999)
Science
, vol.285
, pp. 727-729
-
-
Bauer, S.1
Groh, V.2
Wu, J.3
-
75
-
-
0029861713
-
Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
-
Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996; 93: 12445-50
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 12445-12450
-
-
Groh, V.1
Bahram, S.2
Bauer, S.3
Herman, A.4
Beauchamp, M.5
Spies, T.6
-
76
-
-
0035054469
-
Role of NKG2D in tumor cell lysis mediated by human NK-cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
-
Pende D, Cantoni C, Rivera P et al. Role of NKG2D in tumor cell lysis mediated by human NK-cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 2001; 31: 1076-86
-
(2001)
Eur J Immunol
, vol.31
, pp. 1076-1086
-
-
Pende, D.1
Cantoni, C.2
Rivera, P.3
-
77
-
-
0035286345
-
Co-stimulation of CD8alphabeta T-cells by NKG2D via engagement by MIC induced on virus-infected cells
-
Groh V, Rhinehart R, Randolph-Habecker J, Topp M, Riddell S, Spies T. Co-stimulation of CD8alphabeta T-cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2: 255-60
-
(2001)
Nat Immunol
, vol.2
, pp. 255-260
-
-
Groh, V.1
Rhinehart, R.2
Randolph-Habecker, J.3
Topp, M.4
Riddell, S.5
Spies, T.6
-
78
-
-
0035949563
-
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
-
Cerwenka A, Baron J, Lanier L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 2001; 98: 11521-6
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 11521-11526
-
-
Cerwenka, A.1
Baron, J.2
Lanier, L.3
-
79
-
-
0035855872
-
Rael and H60 ligands of the NKG2D receptor stimulate turnout immunity
-
Diefenbach A, Jensen E, Jamieson A, Raulet D. Rael and H60 ligands of the NKG2D receptor stimulate turnout immunity. Nature 2001; 413: 165-71
-
(2001)
Nature
, vol.413
, pp. 165-171
-
-
Diefenbach, A.1
Jensen, E.2
Jamieson, A.3
Raulet, D.4
-
80
-
-
0035914134
-
Regulation of cutaneous malignancy by gamma delta T cells
-
Girardi M, Oppenheim D, Steele C et al. Regulation of cutaneous malignancy by gamma delta T cells. Science 2001; 294: 605-9
-
(2001)
Science
, vol.294
, pp. 605-609
-
-
Girardi, M.1
Oppenheim, D.2
Steele, C.3
-
81
-
-
0033662145
-
NKT-cells: Facts, functions and fallacies
-
Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT-cells: Facts, functions and fallacies. Immunol Today 2000; 21: 573-83
-
(2000)
Immunol Today
, vol.21
, pp. 573-583
-
-
Godfrey, D.I.1
Hammond, K.J.2
Poulton, L.D.3
Smyth, M.J.4
Baxter, A.G.5
-
82
-
-
0036533337
-
NKT-cells - Conductors of tumor immunity?
-
Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI. NKT-cells - Conductors of tumor immunity? Curr Opin Immunol 2002; 14: 165-71
-
(2002)
Curr Opin Immunol
, vol.14
, pp. 165-171
-
-
Smyth, M.J.1
Crowe, N.Y.2
Hayakawa, Y.3
Takeda, K.4
Yagita, H.5
Godfrey, D.I.6
-
83
-
-
0036591697
-
Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha- galactosylceramide by human CD4(+) and CD8alphabeta(+) T-lymphocytes
-
Gadola SD, Dulphy N, Salio M, Cerundolo V. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha- galactosylceramide by human CD4(+) and CD8alphabeta(+) T-lymphocytes. J Immunol 2002; 168: 5514-20
-
(2002)
J Immunol
, vol.168
, pp. 5514-5520
-
-
Gadola, S.D.1
Dulphy, N.2
Salio, M.3
Cerundolo, V.4
-
84
-
-
0033405176
-
The intestinal epithelial cell: Processing and presentation of antigen to the mucosal immune system
-
Campbell N, Yio XY, So LP, Li Y, Mayer L. The intestinal epithelial cell: Processing and presentation of antigen to the mucosal immune system. Immunol Rev 1999; 172: 315-24
-
(1999)
Immunol Rev
, vol.172
, pp. 315-324
-
-
Campbell, N.1
Yio, X.Y.2
So, L.P.3
Li, Y.4
Mayer, L.5
|